NCT06827236
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06827236
Title A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors BioNTech SE
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | GBR

Facility Status City State Zip Country Details
Hematology - Oncology Associates of the Treasure Coast RECRUITING Port Saint Lucie Florida 34952 United States Details
Winship Cancer Institute of Emory University RECRUITING Atlanta Georgia 30322 United States Details
START Midwest, LLC RECRUITING Grand Rapids Michigan 49546 United States Details
Summit Medical Group RECRUITING Florham Park New Jersey 07932 United States Details
Memorial Sloan Kettering Hospital RECRUITING New York New York 10065 United States Details
South Texas Accelerated Research Therapeutics (START), LLC RECRUITING San Antonio Texas 78229 United States Details
Sichuan Cancer Hospital RECRUITING Chengdu 610072 China Details
Huizhou First Hospital RECRUITING Huizhou 516003 China Details
Fudan University Shanghai Cancer RECRUITING Shanghai 201315 China Details
LLC Arensia Exploratory Medicine RECRUITING Tbilisi 0112 Georgia Details
Institute of Oncology Arensia Exploratory Medicine RECRUITING Chisinau 2025 Moldova Details
Addenbrooke s Hospital RECRUITING Cambridge CB2 0QQ United Kingdom Details
St James's University Hospital RECRUITING Leeds LS9 7TF United Kingdom Details
Royal Free Hospital RECRUITING London NW3 2QG United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field